6.25
price down icon3.40%   -0.22
after-market Dopo l'orario di chiusura: 6.25
loading

Bausch Health Companies Inc Borsa (BHC) Ultime notizie

pulisher
Mar 31, 2025

Oral Mucositis Market reached US$ 1.62 billion in 2023 and - openPR.com

Mar 31, 2025
pulisher
Mar 27, 2025

Bausch + Lomb Brief: Adds Cause "Could Not Immediately Be Explained" - MarketScreener

Mar 27, 2025
pulisher
Mar 27, 2025

Bausch + Lomb Brief: Announcing a Voluntary Recall of Intraocular Lenses (IOLs) On Its enVista Platform - MarketScreener

Mar 27, 2025
pulisher
Mar 27, 2025

Bausch Health to Announce First Quarter Results on April 30 - guardonline.com

Mar 27, 2025
pulisher
Mar 26, 2025

Bausch Health revenue by segment 2021-2024 - Statista

Mar 26, 2025
pulisher
Mar 25, 2025

Bausch Health Upsizes Private Offering to $4.4 Billion - TipRanks

Mar 25, 2025
pulisher
Mar 25, 2025

Bausch Health upsizes senior notes offering to $4.4 billion By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

Bausch Health upsizes senior notes offering to $4.4 billion - Investing.com India

Mar 25, 2025
pulisher
Mar 25, 2025

Bausch Health Prices Upsized Private Offering of Senior Secured Notes - MarketScreener

Mar 25, 2025
pulisher
Mar 25, 2025

Bausch Health Announces Pricing Of Upsized Private Offering Of Senior Secured Notes - Marketscreener.com

Mar 25, 2025
pulisher
Mar 25, 2025

Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes - ACCESS Newswire

Mar 25, 2025
pulisher
Mar 22, 2025

Shareholders in Bausch Health Companies (NYSE:BHC) are in the red if they invested three years ago - Yahoo Finance

Mar 22, 2025
pulisher
Mar 21, 2025

Bausch Health announces debt refinancing plans By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 21, 2025

Bausch Health announces debt refinancing plans - Investing.com

Mar 21, 2025
pulisher
Mar 21, 2025

Bausch Health Announces Conditional Redemption of Senior Notes - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Bausch Health Brief: Announcing Conditional Redemption of Senior Notes -March 21, 2025 at 04:24 pm EDT - MarketScreener

Mar 21, 2025
pulisher
Mar 21, 2025

Bausch Health's Massive $7.4B Debt Overhaul Extends Maturity to 2032 - StockTitan

Mar 21, 2025
pulisher
Mar 21, 2025

After losing 25% in the past year, Bausch Health Companies Inc. (NYSE:BHC) institutional owners must be relieved by the recent gain - simplywall.st

Mar 21, 2025
pulisher
Mar 21, 2025

Bausch Health finance plan gets thumbs up at Raymond James - Cantech Letter

Mar 21, 2025
pulisher
Mar 20, 2025

BHC Stock Price, News and Analysis - Cantech Letter

Mar 20, 2025
pulisher
Mar 20, 2025

Optical Coherence Tomography Devices Market Future Business - openPR

Mar 20, 2025
pulisher
Mar 19, 2025

Raymond James maintains Bausch Health stock Market Perform By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Raymond James maintains Bausch Health stock Market Perform - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Bausch Health seeks $3.8 billion in new credit facilities - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Bausch + Lomb credit rating upgraded to ’B’ at S&P, parent company outlook developing - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Bausch Health seeks $3.8 billion in new credit facilities By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Bausch Health Launches $4 Billion Note Offering to Restructure Debt - TipRanks

Mar 19, 2025
pulisher
Mar 19, 2025

Bausch Health Launches Syndication Of New Senior Secured Credit Facilities Totaling At Least $3.8 Bln - MarketScreener

Mar 19, 2025
pulisher
Mar 19, 2025

Bausch Health Launches $3.8 Billion Credit Facilities -March 19, 2025 at 12:15 pm EDT - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities - ACCESS Newswire

Mar 19, 2025
pulisher
Mar 19, 2025

Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes - ACCESS Newswire

Mar 19, 2025
pulisher
Mar 18, 2025

Intraocular Lens Market Research Methodologies Offers High - openPR

Mar 18, 2025
pulisher
Mar 15, 2025

Bausch Health announces next steps in financining initiative - Yahoo Finance

Mar 15, 2025
pulisher
Mar 14, 2025

Bausch Health Companies Announces Next Steps In Financing Initiative With J.P. Morgan - Marketscreener.com

Mar 14, 2025
pulisher
Mar 14, 2025

Bausch Health seeks financing with J.P. Morgan aid By Investing.com - Investing.com South Africa

Mar 14, 2025
pulisher
Mar 14, 2025

Bausch Health seeks financing with J.P. Morgan aid - Investing.com India

Mar 14, 2025
pulisher
Mar 14, 2025

Bausch Health Brief: Says Has engaged J.P. Morgan in connection with Its previously announced financing objectives - Marketscreener.com

Mar 14, 2025
pulisher
Mar 14, 2025

Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan - Voice Of Alexandria

Mar 14, 2025
pulisher
Mar 14, 2025

Bausch Health Taps JP Morgan to Lead Major Financial Restructuring Initiative - StockTitan

Mar 14, 2025
pulisher
Mar 14, 2025

What is Zacks Research’s Forecast for BHC Q2 Earnings? - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

Acne Market on Track for Major Expansion by 2032, According to DelveInsight | Clinuvel Pharma, Novan, Dermata Therapeutics, ioPharmX, Bausch Health Americas, Inc., Kintor Pharma, Sol-Gel Technologies - Barchart

Mar 12, 2025
pulisher
Mar 12, 2025

Microkeratome Market Detailed In New Research Report 2025 | - openPR

Mar 12, 2025
pulisher
Mar 12, 2025

Overt Hepatic Encephalopathy Treatment Market: Key - openPR

Mar 12, 2025
pulisher
Mar 10, 2025

Bausch Health Companies Inc. (NYSE:BHC) Receives $7.42 Consensus PT from Analysts - Defense World

Mar 10, 2025
pulisher
Mar 07, 2025

Cosmetic Surgery Market Forecast Report and Company - GlobeNewswire

Mar 07, 2025
pulisher
Mar 07, 2025

Cosmetic Surgery Market Forecast Report and Company Analysis 2025-2033 Featuring AbbVie, Cutera, Sientra, Bausch Health, Johnson & Johnson, Apyx Medical, Hologic, Merz Pharma, Galderma, Cynosure - Yahoo Finance

Mar 07, 2025
$32.53
price down icon 1.48%
$97.93
price up icon 0.34%
$8.60
price down icon 1.26%
$107.00
price down icon 3.25%
$306.88
price down icon 0.45%
$131.87
price down icon 0.04%
Capitalizzazione:     |  Volume (24 ore):